blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2397122

EP2397122 - Formulations of neramexane dosage forms [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.03.2015
Database last updated on 24.08.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): LU, TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Merz Pharma GmbH & Co. KGaA
Eckenheimer Landstrasse 100
60318 Frankfurt / DE
[2011/51]
Inventor(s)01 / Seiller, Erhard
Mozartstrasse 12a
61130 Nidderau / DE
02 / Hauptmeier, Bernhard
Neue Weinbergstrasse 10
63571 Gelnhausen / DE
03 / Yang, Yan
60 George Street
Roslyn Heights New York 11577 / US
04 / Janjikhel, Rajiv
58 Sunflower Ridge Road
South Setauket New York 11720 / US
05 / Rao, Niranjan
88 Ketcham Road
Belle Mead, NJ 08502 / US
06 / Periclou, Antonia
89 Beckwith Place
Rutherford, NJ 07070 / US
07 / Abramowitz, Wattanporn
4 Abbington Lane
West Windsor, NJ 08550 / US
08 / Dedhiya, Mahendra G.
1 Lea Court
Pomona New York 10970 / US
 [2012/19]
Former [2012/03]01 / Seiller, Erhard
Mozartstrasse 12a
61130 Nidderau / DE
02 / Hauptmeier, Bernhard
Neue Weinbergstrasse 10
63571 Gelnhausen / DE
03 / Yang, Yan
60 George Street
Roslyn Heights New York 11577 / US
04 / Janjikhel, Rajiv
58 Sunflower Ridge Road
South Setauket New York 11720 / US
05 / Rao, Niranjan
88 Ketcham Road
Belle Mead, NJ 08502 / US
06 / Periclou, Antonia
31 River Court, Apt. 101
Jersey City, New Jersey 07310 / US
07 / Abramowitz, Wattanporn
4 Abbington Lane
West Windsor, NJ 08550 / US
08 / Dedhiya, Mahendra G.
1 Lea Court
Pomona New York 10970 / US
Representative(s)Goddard, Christopher Robert
Dehns
St Bride's House
10 Salisbury Square
London
EC4Y 8JD / GB
[2014/20]
Former [2011/51]Goddard, Christopher Robert
Dehns St Bride's House 10 Salisbury Square London
EC4Y 8JD / GB
Application number, filing date11179637.116.06.2005
[2011/51]
Priority number, dateUS20040581244P17.06.2004         Original published format: US 581244 P
[2011/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2397122
Date:21.12.2011
Language:EN
[2011/51]
Type: A3 Search report 
No.:EP2397122
Date:25.01.2012
Language:EN
[2012/04]
Type: B1 Patent specification 
No.:EP2397122
Date:14.05.2014
Language:EN
[2014/20]
Search report(s)(Supplementary) European search report - dispatched on:EP22.12.2011
ClassificationIPC:A61K9/20, A61K31/13
[2011/51]
CPC:
A61K9/0095 (EP); A61K31/13 (EP,KR); A61K31/40 (EP);
A61K9/20 (KR); A61K9/2013 (EP); A61K9/2054 (EP);
A61K9/2095 (EP); A61K9/28 (KR); A61P25/00 (EP);
A61P25/28 (EP); Y02A50/30 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/51]
Extension statesAL25.07.2012
BA25.07.2012
HR25.07.2012
LV25.07.2012
MK25.07.2012
YU25.07.2012
TitleGerman:Formulierungen aus Neramexan-Dosierformen[2011/51]
English:Formulations of neramexane dosage forms[2011/51]
French:Formulations de formes pharmaceutiques de néramexane[2011/51]
Examination procedure25.07.2012Amendment by applicant (claims and/or description)
25.07.2012Examination requested  [2012/36]
31.01.2013Despatch of a communication from the examining division (Time limit: M04)
10.06.2013Reply to a communication from the examining division
28.11.2013Communication of intention to grant the patent
28.03.2014Fee for grant paid
28.03.2014Fee for publishing/printing paid
07.04.2014Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP05857458.3  / EP1765287
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050857458) is  24.01.2011
Opposition(s)17.02.2015No opposition filed within time limit [2015/17]
Fees paidRenewal fee
31.08.2011Renewal fee patent year 03
31.08.2011Renewal fee patent year 04
31.08.2011Renewal fee patent year 05
31.08.2011Renewal fee patent year 06
31.08.2011Renewal fee patent year 07
31.03.2012Renewal fee patent year 08
10.06.2013Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.06.2005
AT14.05.2014
BE14.05.2014
BG14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
MC14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
TR14.05.2014
IE16.06.2014
LU16.06.2014
CH30.06.2014
LI30.06.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
[2016/33]
Former [2016/32]HU16.06.2005
AT14.05.2014
BE14.05.2014
BG14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
MC14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
IE16.06.2014
CH30.06.2014
LI30.06.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2016/25]AT14.05.2014
BE14.05.2014
BG14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
MC14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
IE16.06.2014
CH30.06.2014
LI30.06.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2016/21]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
MC14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
IE16.06.2014
CH30.06.2014
LI30.06.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2015/36]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SI14.05.2014
SK14.05.2014
IE16.06.2014
CH30.06.2014
LI30.06.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2015/21]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SK14.05.2014
IE16.06.2014
CH30.06.2014
LI30.06.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2015/20]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SK14.05.2014
CH30.06.2014
LI30.06.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2015/12]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
NL14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SK14.05.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2015/11]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
PL14.05.2014
RO14.05.2014
SE14.05.2014
SK14.05.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2015/10]AT14.05.2014
BE14.05.2014
CY14.05.2014
CZ14.05.2014
DK14.05.2014
EE14.05.2014
FI14.05.2014
LT14.05.2014
PL14.05.2014
SE14.05.2014
SK14.05.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2015/08]AT14.05.2014
BE14.05.2014
CY14.05.2014
DK14.05.2014
FI14.05.2014
LT14.05.2014
PL14.05.2014
SE14.05.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2015/02]AT14.05.2014
CY14.05.2014
FI14.05.2014
LT14.05.2014
PL14.05.2014
SE14.05.2014
GR15.08.2014
IS14.09.2014
PT15.09.2014
Former [2014/51]AT14.05.2014
CY14.05.2014
FI14.05.2014
LT14.05.2014
PL14.05.2014
SE14.05.2014
GR15.08.2014
IS14.09.2014
Former [2014/50]CY14.05.2014
FI14.05.2014
LT14.05.2014
PL14.05.2014
SE14.05.2014
GR15.08.2014
IS14.09.2014
Former [2014/49]CY14.05.2014
FI14.05.2014
LT14.05.2014
IS14.09.2014
Former [2014/48]CY14.05.2014
LT14.05.2014
Former [2014/47]CY14.05.2014
Documents cited:Search[IY]US6034134  (GOLD MARKUS [DE], et al) [I] 1-15 * column 1, lines 10-16 * * column 20, lines 45-49 * * column 21, lines 1-15 * * column 35, lines 33,39-44 * * column 5, line 10; claim 5 * * the whole document * [Y] 1-15;
 [IY]US2003166634  (HENRICH MARKUS [DE], et al) [I] 1-15 * claim 4 * * paragraphs [0298] , [0303] * * paragraph [0006] * * paragraph [0344] * [Y] 1-15;
 [AP]WO2005044228  (MERZ PHARMA GMBH & CO KGAA [DE], et al) [AP] 1-15 * the whole document * * example - ** claim - *
by applicantUS4122193
 US4273774
 US5061703
 US5234956
 US5334618
 US5382601
 US5455279
 US5506231
 US5614560
 US6034134
 US6071966
 US6194000
 US6413556
 US6444702
 US6479553
 US2003166634
 US2004034055
    - "Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations", CDER, FOOD AND DRUG ADMINISTRATION, (199709), page 17
    - NEUROPHARMACOLOGY, (199906), vol. 38, no. 6, pages 735 - 767
    - Pharmaceutical Dosage Forms: Tablets, MARCEL DEKKER, INC., (1982), vol. 3, pages 101 - 272
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.